These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9736005)
1. Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. Little KY; McLaughlin DP; Zhang L; McFinton PR; Dalack GW; Cook EH; Cassin BJ; Watson SJ Arch Gen Psychiatry; 1998 Sep; 55(9):793-9. PubMed ID: 9736005 [TBL] [Abstract][Full Text] [Related]
2. Striatal dopaminergic abnormalities in human cocaine users. Little KY; Zhang L; Desmond T; Frey KA; Dalack GW; Cassin BJ Am J Psychiatry; 1999 Feb; 156(2):238-45. PubMed ID: 9989560 [TBL] [Abstract][Full Text] [Related]
3. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632 [TBL] [Abstract][Full Text] [Related]
4. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration. Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056 [TBL] [Abstract][Full Text] [Related]
5. Dopamine transport function is elevated in cocaine users. Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476 [TBL] [Abstract][Full Text] [Related]
6. Cocaine use increases [3H]WIN 35428 binding sites in human striatum. Little KY; Kirkman JA; Carroll FI; Clark TB; Duncan GE Brain Res; 1993 Nov; 628(1-2):17-25. PubMed ID: 8313144 [TBL] [Abstract][Full Text] [Related]
7. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869 [TBL] [Abstract][Full Text] [Related]
8. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Letchworth SR; Daunais JB; Hedgecock AA; Porrino LJ Brain Res; 1997 Mar; 750(1-2):214-22. PubMed ID: 9098547 [TBL] [Abstract][Full Text] [Related]
9. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Little KY; McLaughlin DP; Zhang L; Livermore CS; Dalack GW; McFinton PR; DelProposto ZS; Hill E; Cassin BJ; Watson SJ; Cook EH Am J Psychiatry; 1998 Feb; 155(2):207-13. PubMed ID: 9464199 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065 [TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428. Coulter CL; Happe HK; Murrin LC Brain Res Dev Brain Res; 1997 Dec; 104(1-2):55-62. PubMed ID: 9466707 [TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532 [TBL] [Abstract][Full Text] [Related]
14. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain. Little KY; Kirkman JA; Carroll FI; Breese GR; Duncan GE J Neurochem; 1993 Dec; 61(6):1996-2006. PubMed ID: 8245956 [TBL] [Abstract][Full Text] [Related]
15. Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55. Coulter CL; Happe HK; Bergman DA; Murrin LC Brain Res; 1995 Sep; 690(2):217-24. PubMed ID: 8535839 [TBL] [Abstract][Full Text] [Related]
17. Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe. Little KY; Carroll FI; Cassin BJ J Pharmacol Exp Ther; 1995 Sep; 274(3):1473-83. PubMed ID: 7562524 [TBL] [Abstract][Full Text] [Related]
18. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Suzuki M; Desmond TJ; Albin RL; Frey KA Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403 [TBL] [Abstract][Full Text] [Related]
19. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter mRNA in autopsy studies of chronic cocaine users. Chen L; Segal DM; Moraes CT; Mash DC Brain Res Mol Brain Res; 1999 Nov; 73(1-2):181-5. PubMed ID: 10581411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]